BCAL Diagnostics Limited (AU:BDX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BCAL Diagnostics Limited is set to hold its Annual General Meeting on November 22, 2024, where shareholders will review financial reports and vote on key resolutions, including the re-election of director Ronald Phillips. Investors have the opportunity to engage and vote, either in person or by proxy, on various resolutions that will shape the company’s future. This meeting is a pivotal event for stakeholders to assess BCAL’s strategic direction and governance.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.